Look for Drugs and Conditions

Zydus Cadila drug for liver, diabetes gets USFDA nod

 DTMT NETWORK
Zudus Cadila has got the final approval from the USFDA to market Ursodiol Capsules USP, 300 mg. Ursodiol is in a class of medications called gallstone dissolution agents. It is used to treat people with primary biliary cirrhosis (PBC; an autoimmune liver disease).

The company also received tentative approval from the drug regulator to market Linagliptin and Metformin Hydrochloride Tabs (US RLD: Jentadueto® Tablets) in the strengths of 2.5 mg/500 mg, 2.5 mg/850 mg, and 2.5 mg/1,000 mg. It is used along with diet and exercise to improve control of blood sugar levels in adults with type 2 diabetes mellitus.

Both drugs will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.


0 Comments
Be first to post your comments

Post your comment

Related Articles

Ad 5